Cargando…
Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
Coronavirus disease‐2019 (COVID‐19) infection and its severity can be explained by the concentration of glycosylated severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) viral particles in the lung epithelium, the concentration of glycosylated angiotensin‐converting enzyme receptor 2 (ACE2)...
Autor principal: | Brufsky, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262330/ https://www.ncbi.nlm.nih.gov/pubmed/32293710 http://dx.doi.org/10.1002/jmv.25887 |
Ejemplares similares
-
DC/L‐SIGNs of hope in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020) -
Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021) -
The Rise and Fall of Hydroxychloroquine with the COVID-19 Pandemic: Narrative Review of Selected Data
por: Tang, Wei, et al.
Publicado: (2021) -
Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020) -
Ratcheting down the virulence of SARS‐CoV‐2 in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)